All News

2058 articles, sorted by publication time.

Medical Diagnostics · us

Roche respiratory test receives FDA clearance, adds pertussis and offers five panel configurations

Respiratory infections have similar symptoms, but testing may not always need to cover the same pathogens. Roche’s next-generation RP3 panel has received marketing clearance in the United States, allowing laboratories to choose testing coverage based on local disease prevalence; whether it can improve medication use and care workflows still requires clinical validation.